Izotropic CEO Dr. John McGraw sits down with Justin to discuss and give updates on the IzoView Prototype, Clinical Trials, Patent Portfolio, and Strategic Partnerships.
Izotropic Corporation is the only publicly-traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers. IzoView produces high resolution breast images in true 3D with low radiation dose levels, and is ideal for imaging patients with dense breast tissue. A single 10 second scan acquires approximately 500 images, without painful breast compression or continual technician breast handling, providing a more comfortable patient experience.
CSE:IZO | OTCQB:IZOZF
